Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Peripheral Angioplasty Market

ID: MRFR/HC/14606-HCR
128 Pages
Vikita Thakur
Last Updated: April 06, 2026

Peripheral Angioplasty Market Research Report Information By Product (Balloon Catheters, Stents, and Guidewires), By End User (Hospitals, Ambulatory Surgical Centers, and Cardiac Catheterization Centers) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Peripheral Angioplasty Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Product (USD Billion)
  49.     4.1.1 Balloon Catheters
  50.     4.1.2 Stents
  51.     4.1.3 Guidewires
  52.   4.2 Healthcare, BY End User (USD Billion)
  53.     4.2.1 Hospitals
  54.     4.2.2 Ambulatory Surgical Centers
  55.     4.2.3 Cardiac Catheterization Centers
  56.   4.3 Healthcare, BY Region (USD Billion)
  57.     4.3.1 North America
  58.       4.3.1.1 US
  59.       4.3.1.2 Canada
  60.     4.3.2 Europe
  61.       4.3.2.1 Germany
  62.       4.3.2.2 UK
  63.       4.3.2.3 France
  64.       4.3.2.4 Russia
  65.       4.3.2.5 Italy
  66.       4.3.2.6 Spain
  67.       4.3.2.7 Rest of Europe
  68.     4.3.3 APAC
  69.       4.3.3.1 China
  70.       4.3.3.2 India
  71.       4.3.3.3 Japan
  72.       4.3.3.4 South Korea
  73.       4.3.3.5 Malaysia
  74.       4.3.3.6 Thailand
  75.       4.3.3.7 Indonesia
  76.       4.3.3.8 Rest of APAC
  77.     4.3.4 South America
  78.       4.3.4.1 Brazil
  79.       4.3.4.2 Mexico
  80.       4.3.4.3 Argentina
  81.       4.3.4.4 Rest of South America
  82.     4.3.5 MEA
  83.       4.3.5.1 GCC Countries
  84.       4.3.5.2 South Africa
  85.       4.3.5.3 Rest of MEA
  86. 5 SECTION V: COMPETITIVE ANALYSIS
  87.   5.1 Competitive Landscape
  88.     5.1.1 Overview
  89.     5.1.2 Competitive Analysis
  90.     5.1.3 Market share Analysis
  91.     5.1.4 Major Growth Strategy in the Healthcare
  92.     5.1.5 Competitive Benchmarking
  93.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  94.     5.1.7 Key developments and growth strategies
  95.       5.1.7.1 New Product Launch/Service Deployment
  96.       5.1.7.2 Merger & Acquisitions
  97.       5.1.7.3 Joint Ventures
  98.     5.1.8 Major Players Financial Matrix
  99.       5.1.8.1 Sales and Operating Income
  100.       5.1.8.2 Major Players R&D Expenditure. 2023
  101.   5.2 Company Profiles
  102.     5.2.1 Medtronic (US)
  103.       5.2.1.1 Financial Overview
  104.       5.2.1.2 Products Offered
  105.       5.2.1.3 Key Developments
  106.       5.2.1.4 SWOT Analysis
  107.       5.2.1.5 Key Strategies
  108.     5.2.2 Boston Scientific (US)
  109.       5.2.2.1 Financial Overview
  110.       5.2.2.2 Products Offered
  111.       5.2.2.3 Key Developments
  112.       5.2.2.4 SWOT Analysis
  113.       5.2.2.5 Key Strategies
  114.     5.2.3 Abbott Laboratories (US)
  115.       5.2.3.1 Financial Overview
  116.       5.2.3.2 Products Offered
  117.       5.2.3.3 Key Developments
  118.       5.2.3.4 SWOT Analysis
  119.       5.2.3.5 Key Strategies
  120.     5.2.4 B. Braun Melsungen AG (DE)
  121.       5.2.4.1 Financial Overview
  122.       5.2.4.2 Products Offered
  123.       5.2.4.3 Key Developments
  124.       5.2.4.4 SWOT Analysis
  125.       5.2.4.5 Key Strategies
  126.     5.2.5 Terumo Corporation (JP)
  127.       5.2.5.1 Financial Overview
  128.       5.2.5.2 Products Offered
  129.       5.2.5.3 Key Developments
  130.       5.2.5.4 SWOT Analysis
  131.       5.2.5.5 Key Strategies
  132.     5.2.6 Cordis Corporation (US)
  133.       5.2.6.1 Financial Overview
  134.       5.2.6.2 Products Offered
  135.       5.2.6.3 Key Developments
  136.       5.2.6.4 SWOT Analysis
  137.       5.2.6.5 Key Strategies
  138.     5.2.7 Cook Medical (US)
  139.       5.2.7.1 Financial Overview
  140.       5.2.7.2 Products Offered
  141.       5.2.7.3 Key Developments
  142.       5.2.7.4 SWOT Analysis
  143.       5.2.7.5 Key Strategies
  144.     5.2.8 AngioDynamics (US)
  145.       5.2.8.1 Financial Overview
  146.       5.2.8.2 Products Offered
  147.       5.2.8.3 Key Developments
  148.       5.2.8.4 SWOT Analysis
  149.       5.2.8.5 Key Strategies
  150.     5.2.9 Asahi Intecc Co., Ltd. (JP)
  151.       5.2.9.1 Financial Overview
  152.       5.2.9.2 Products Offered
  153.       5.2.9.3 Key Developments
  154.       5.2.9.4 SWOT Analysis
  155.       5.2.9.5 Key Strategies
  156.   5.3 Appendix
  157.     5.3.1 References
  158.     5.3.2 Related Reports
  159. 6 LIST OF FIGURES
  160.   6.1 MARKET SYNOPSIS
  161.   6.2 NORTH AMERICA MARKET ANALYSIS
  162.   6.3 US MARKET ANALYSIS BY PRODUCT
  163.   6.4 US MARKET ANALYSIS BY END USER
  164.   6.5 CANADA MARKET ANALYSIS BY PRODUCT
  165.   6.6 CANADA MARKET ANALYSIS BY END USER
  166.   6.7 EUROPE MARKET ANALYSIS
  167.   6.8 GERMANY MARKET ANALYSIS BY PRODUCT
  168.   6.9 GERMANY MARKET ANALYSIS BY END USER
  169.   6.10 UK MARKET ANALYSIS BY PRODUCT
  170.   6.11 UK MARKET ANALYSIS BY END USER
  171.   6.12 FRANCE MARKET ANALYSIS BY PRODUCT
  172.   6.13 FRANCE MARKET ANALYSIS BY END USER
  173.   6.14 RUSSIA MARKET ANALYSIS BY PRODUCT
  174.   6.15 RUSSIA MARKET ANALYSIS BY END USER
  175.   6.16 ITALY MARKET ANALYSIS BY PRODUCT
  176.   6.17 ITALY MARKET ANALYSIS BY END USER
  177.   6.18 SPAIN MARKET ANALYSIS BY PRODUCT
  178.   6.19 SPAIN MARKET ANALYSIS BY END USER
  179.   6.20 REST OF EUROPE MARKET ANALYSIS BY PRODUCT
  180.   6.21 REST OF EUROPE MARKET ANALYSIS BY END USER
  181.   6.22 APAC MARKET ANALYSIS
  182.   6.23 CHINA MARKET ANALYSIS BY PRODUCT
  183.   6.24 CHINA MARKET ANALYSIS BY END USER
  184.   6.25 INDIA MARKET ANALYSIS BY PRODUCT
  185.   6.26 INDIA MARKET ANALYSIS BY END USER
  186.   6.27 JAPAN MARKET ANALYSIS BY PRODUCT
  187.   6.28 JAPAN MARKET ANALYSIS BY END USER
  188.   6.29 SOUTH KOREA MARKET ANALYSIS BY PRODUCT
  189.   6.30 SOUTH KOREA MARKET ANALYSIS BY END USER
  190.   6.31 MALAYSIA MARKET ANALYSIS BY PRODUCT
  191.   6.32 MALAYSIA MARKET ANALYSIS BY END USER
  192.   6.33 THAILAND MARKET ANALYSIS BY PRODUCT
  193.   6.34 THAILAND MARKET ANALYSIS BY END USER
  194.   6.35 INDONESIA MARKET ANALYSIS BY PRODUCT
  195.   6.36 INDONESIA MARKET ANALYSIS BY END USER
  196.   6.37 REST OF APAC MARKET ANALYSIS BY PRODUCT
  197.   6.38 REST OF APAC MARKET ANALYSIS BY END USER
  198.   6.39 SOUTH AMERICA MARKET ANALYSIS
  199.   6.40 BRAZIL MARKET ANALYSIS BY PRODUCT
  200.   6.41 BRAZIL MARKET ANALYSIS BY END USER
  201.   6.42 MEXICO MARKET ANALYSIS BY PRODUCT
  202.   6.43 MEXICO MARKET ANALYSIS BY END USER
  203.   6.44 ARGENTINA MARKET ANALYSIS BY PRODUCT
  204.   6.45 ARGENTINA MARKET ANALYSIS BY END USER
  205.   6.46 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT
  206.   6.47 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
  207.   6.48 MEA MARKET ANALYSIS
  208.   6.49 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT
  209.   6.50 GCC COUNTRIES MARKET ANALYSIS BY END USER
  210.   6.51 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT
  211.   6.52 SOUTH AFRICA MARKET ANALYSIS BY END USER
  212.   6.53 REST OF MEA MARKET ANALYSIS BY PRODUCT
  213.   6.54 REST OF MEA MARKET ANALYSIS BY END USER
  214.   6.55 KEY BUYING CRITERIA OF HEALTHCARE
  215.   6.56 RESEARCH PROCESS OF MRFR
  216.   6.57 DRO ANALYSIS OF HEALTHCARE
  217.   6.58 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  218.   6.59 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  219.   6.60 SUPPLY / VALUE CHAIN: HEALTHCARE
  220.   6.61 HEALTHCARE, BY PRODUCT, 2024 (% SHARE)
  221.   6.62 HEALTHCARE, BY PRODUCT, 2024 TO 2035 (USD Billion)
  222.   6.63 HEALTHCARE, BY END USER, 2024 (% SHARE)
  223.   6.64 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
  224.   6.65 BENCHMARKING OF MAJOR COMPETITORS
  225. 7 LIST OF TABLES
  226.   7.1 LIST OF ASSUMPTIONS
  227.     7.1.1
  228.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  229.     7.2.1 BY PRODUCT, 2025-2035 (USD Billion)
  230.     7.2.2 BY END USER, 2025-2035 (USD Billion)
  231.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  232.     7.3.1 BY PRODUCT, 2025-2035 (USD Billion)
  233.     7.3.2 BY END USER, 2025-2035 (USD Billion)
  234.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  235.     7.4.1 BY PRODUCT, 2025-2035 (USD Billion)
  236.     7.4.2 BY END USER, 2025-2035 (USD Billion)
  237.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  238.     7.5.1 BY PRODUCT, 2025-2035 (USD Billion)
  239.     7.5.2 BY END USER, 2025-2035 (USD Billion)
  240.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  241.     7.6.1 BY PRODUCT, 2025-2035 (USD Billion)
  242.     7.6.2 BY END USER, 2025-2035 (USD Billion)
  243.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  244.     7.7.1 BY PRODUCT, 2025-2035 (USD Billion)
  245.     7.7.2 BY END USER, 2025-2035 (USD Billion)
  246.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  247.     7.8.1 BY PRODUCT, 2025-2035 (USD Billion)
  248.     7.8.2 BY END USER, 2025-2035 (USD Billion)
  249.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  250.     7.9.1 BY PRODUCT, 2025-2035 (USD Billion)
  251.     7.9.2 BY END USER, 2025-2035 (USD Billion)
  252.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  253.     7.10.1 BY PRODUCT, 2025-2035 (USD Billion)
  254.     7.10.2 BY END USER, 2025-2035 (USD Billion)
  255.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  256.     7.11.1 BY PRODUCT, 2025-2035 (USD Billion)
  257.     7.11.2 BY END USER, 2025-2035 (USD Billion)
  258.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  259.     7.12.1 BY PRODUCT, 2025-2035 (USD Billion)
  260.     7.12.2 BY END USER, 2025-2035 (USD Billion)
  261.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  262.     7.13.1 BY PRODUCT, 2025-2035 (USD Billion)
  263.     7.13.2 BY END USER, 2025-2035 (USD Billion)
  264.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  265.     7.14.1 BY PRODUCT, 2025-2035 (USD Billion)
  266.     7.14.2 BY END USER, 2025-2035 (USD Billion)
  267.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  268.     7.15.1 BY PRODUCT, 2025-2035 (USD Billion)
  269.     7.15.2 BY END USER, 2025-2035 (USD Billion)
  270.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  271.     7.16.1 BY PRODUCT, 2025-2035 (USD Billion)
  272.     7.16.2 BY END USER, 2025-2035 (USD Billion)
  273.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  274.     7.17.1 BY PRODUCT, 2025-2035 (USD Billion)
  275.     7.17.2 BY END USER, 2025-2035 (USD Billion)
  276.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  277.     7.18.1 BY PRODUCT, 2025-2035 (USD Billion)
  278.     7.18.2 BY END USER, 2025-2035 (USD Billion)
  279.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  280.     7.19.1 BY PRODUCT, 2025-2035 (USD Billion)
  281.     7.19.2 BY END USER, 2025-2035 (USD Billion)
  282.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  283.     7.20.1 BY PRODUCT, 2025-2035 (USD Billion)
  284.     7.20.2 BY END USER, 2025-2035 (USD Billion)
  285.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  286.     7.21.1 BY PRODUCT, 2025-2035 (USD Billion)
  287.     7.21.2 BY END USER, 2025-2035 (USD Billion)
  288.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  289.     7.22.1 BY PRODUCT, 2025-2035 (USD Billion)
  290.     7.22.2 BY END USER, 2025-2035 (USD Billion)
  291.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  292.     7.23.1 BY PRODUCT, 2025-2035 (USD Billion)
  293.     7.23.2 BY END USER, 2025-2035 (USD Billion)
  294.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  295.     7.24.1 BY PRODUCT, 2025-2035 (USD Billion)
  296.     7.24.2 BY END USER, 2025-2035 (USD Billion)
  297.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  298.     7.25.1 BY PRODUCT, 2025-2035 (USD Billion)
  299.     7.25.2 BY END USER, 2025-2035 (USD Billion)
  300.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  301.     7.26.1 BY PRODUCT, 2025-2035 (USD Billion)
  302.     7.26.2 BY END USER, 2025-2035 (USD Billion)
  303.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  304.     7.27.1 BY PRODUCT, 2025-2035 (USD Billion)
  305.     7.27.2 BY END USER, 2025-2035 (USD Billion)
  306.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  307.     7.28.1 BY PRODUCT, 2025-2035 (USD Billion)
  308.     7.28.2 BY END USER, 2025-2035 (USD Billion)
  309.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  310.     7.29.1 BY PRODUCT, 2025-2035 (USD Billion)
  311.     7.29.2 BY END USER, 2025-2035 (USD Billion)
  312.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  313.     7.30.1 BY PRODUCT, 2025-2035 (USD Billion)
  314.     7.30.2 BY END USER, 2025-2035 (USD Billion)
  315.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  316.     7.31.1
  317.   7.32 ACQUISITION/PARTNERSHIP
  318.     7.32.1

Healthcare Market Segmentation

Healthcare By Product (USD Billion, 2025-2035)

  • Balloon Catheters
  • Stents
  • Guidewires

Healthcare By End User (USD Billion, 2025-2035)

  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Catheterization Centers

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions